Phenotypic and genetic relationships among temperament, immune, and carcass traits in beef cattle

Master of ScienceDepartment of Animal Sciences and IndustryJennifer Minick-BormannCattle temperament has historically influenced selection decisions due to ease of handling. However, temperament may also influence economically relevant traits. The purpose of this study was to investigate relationships between temperament, Bovine Respiratory Disease (BRD) incidence, and resulting carcass merit in feedlot steers. Across a two year period, 2,870 crossbred steers were shipped from a single ranch source to a feedlot. At the time of feedlot placement, as well as at the time of reimplantation, temperament was measured via chute score (CS) and exit velocity (EV). Blood samples were taken upon arrival to the feedlot to determine circulating concentrations of interleukin 8 (IL-8) and cortisol, both of which are involved in immune function. Performance traits, including weight and gains, were measured at feedlot placement (d 0), reimplantation (d 73-100), and again 59 to 70 days later. Recorded carcass data included HCW (HCW), USDA yield grade (YG), marbling score (MS), ribeye area, and lung scores. Phenotypic statistical analysis was performed with SAS statistical software (SAS Inst., Inc., Cary, NC) and genetic parameters were estimated using ASREML (Ver. 3.0, VSN International, Ltd., Hemel Hempstead, UK). The pedigree file included records of 7,177 animals with up to 7 generation of pedigree. Contemporary group (CG, n=11) included initial ranch unit, date of arrival to the feedlot, feedlot pen, and processing dates. Fixed effects included in the model were pre-feedlot entry BRD treatment and CG. Cattle with higher CS at placement subsequently had more BRD incidence (P < 0.01). There was a positive phenotypic correlation between placement CS and blood cortisol concentrations (r = 0.07; P< 0.01), and cattle with higher cortisol concentration contracted BRD more often than their calmer peers (P < 0.05). Circulating IL-8 concentration had no influence on feedlot health. At the time of reimplantation, cattle that had been treated for BRD in the feedlot had lower chute scores (P < 0.001). Heritability estimates for CS at placement, EV at placement, CS at reimplantation, and EV at reimplantation were 0.23, 0.17, 0.19, and 0.27, respectively. BRD incidence had a negative genetic correlation with all measures of temperament recorded at the second processing period

Genetic relationships among temperament, immune function, and carcass merit

Cattle producers historically have selected for docile temperaments simply for management convenience because calmer animals are conducive to safe environments for their peers as well as their handlers. As many producers would acknowledge, there seems to be a relationship between temperament and health, and calmer cattle tend to frequent the working chute for treatment of disease less often. Positive correlations have been found in cattle between temperament traits (chute scores, pen scores, and chute exit velocities) and cortisol concentration in the blood, suggesting that more excitable cattle are easily stressed (Curley et al., 2006; Cooke et al., 2009). In addition, Curley et al. (2007) found that easily excitable animals sustain elevated cortisol concentrations for a longer duration and had greater pituitary and adrenal responses following a stressor than calm cattle. Temperamental cattle have significantly higher mean temperament responses at all points (Oliphint, 2006). Higher basal serum cortisol concentrations may suggest that easily excitable cattle are chronically stressed (Curley et al., 2007), possibly resulting in a compromised immune system, illness, and decreased fat and protein deposition. Common measures of cattle temperament are pen scores, chute scores, and exit velocities. Temperament appears to be moderately heritable, with estimates ranging from 0.15 to 0.44 (Burrow and Corbet, 2000; Kadel et al., 2006; Schrode and Hammack, 1971; Stricklin et al., 1980; Fordyce et al., 1988). If genetic correlations are found between temperament and production traits or immunological factors, they may aid cattle breeders in producing profitable cattle. Such relationships have been found between exit velocity and hot carcass weight (r = -0.54), exit velocity and marbling score (r = 0.10), exit velocity and yield grade (r = -0.22) (Nkrumah et al., 2007), and post-weaning weight gain and exit velocity (Weaber et al., 2006). Bovine respiratory disease (BRD) susceptibility has been estimated to be lowly heritable (Muggli-Cockett et al., 1992; Snowder et al., 2005, 2006, 2007; Schneider et al., 2008). This study was conducted to further investigate the genetic relationships between cattle temperament measured by chute score and exit velocity, immunological factors, and a range of economically relevant performance traits

Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

Genetic relationships among temperament, immune function, and carcass merit in beef cattle

Cattle producers historically have selected for docile temperaments simply for management convenience because calmer animals are conducive to safe environments for their peers as well as their handlers. As many producers would acknowledge, there seems to be a relationship between temperament and health, and calmer cattle tend to frequent the working chute for treatment of disease less often. Positive correlations have been found in cattle between temperament traits (chute scores, pen scores, and chute exit velocities) and cortisol concentration in the blood, suggesting that more excitable cattle are easily stressed (Curley et al., 2006; Cooke et al., 2009). In addition, Curley et al. (2007) found that easily excitable animals sustain elevated cortisol concentrations for a longer duration and had greater pituitary and adrenal responses following a stressor than calm cattle. Temperamental cattle have significantly higher mean temperament responses at all points (Oliphint, 2006). Higher basal serum cortisol concentrations may suggest that easily excitable cattle are chronically stressed (Curley et al., 2007), possibly resulting in a compromised immune system, illness, and decreased fat and protein deposition. Common measures of cattle temperament are pen scores, chute scores, and exit velocities. Temperament appears to be moderately heritable, with estimates ranging from 0.15 to 0.44 (Burrow and Corbet, 2000; Kadel et al., 2006; Schrode and Hammack, 1971; Stricklin et al., 1980; Fordyce et al., 1988). If genetic correlations are found between temperament and production traits or immunological factors, they may aid cattle breeders in producing profitable cattle. Such relationships have been found between exit velocity and hot carcass weight (r = -0.54), exit velocity and marbling score (r = 0.10), exit velocity and yield grade (r = -0.22) (Nkrumah et al., 2007), and post-weaning weight gain and exit velocity (Weaber et al., 2006). Bovine respiratory disease (BRD) susceptibility has been estimated to be lowly heritable (Muggli-Cockett et al., 1992; Snowder et al., 2005, 2006, 2007; Schneider et al., 2008). This study was conducted to further investigate the genetic relationships between cattle temperament measured by chute score and exit velocity, immunological factors, and a range of economically relevant performance traits

Temperament can be an indicator of feedlot performance and carcass merit in beef cattle

Cattle producers historically have selected for docile temperaments simply for management convenience because calmer animals are conducive to safe environments for their peers as well as their handlers. As many producers would acknowledge, however, there seems to be a relationship between temperament and cattle health, and calmer cattle tend to frequent the working chute for treatment of disease less often. Positive correlations have been found in cattle between temperament traits (chute scores, pen scores, and chute exit velocities) and cortisol concentration in the blood, suggesting that more excitable cattle are easily stressed (Curley et al., 2006; Cooke et al., 2009). Curley et al. (2007) also found that easily excitable animals sustain elevated cortisol concentrations for a longer duration and have greater pituitary and adrenal responses following a stressor than calm cattle. Temperamental cattle have significantly higher mean temperament responses at all points (Oliphint, 2006). Higher basal serum cortisol concentrations may suggest that easily excitable cattle are chronically stressed (Curley et al., 2007), possibly resulting in a compromised immune system, illness, and decreased fat and protein deposition. This study was conducted to further investigate the relationships between cattle temperament (measured by chute score and exit velocity), immunological factors, and a range of economically relevant performance traits

Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration

Background and Purpose: The AFFINITY trial (Assessment of Fluoxetine in Stroke Recovery) reported that oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and seizures. After trial medication was ceased at 6 months, survivors were followed to 12 months post-randomization. This preplanned secondary analysis aimed to determine any sustained or delayed effects of fluoxetine at 12 months post-randomization. Methods: AFFINITY was a randomized, parallel-group, double-blind, placebo-controlled trial in adults (n=1280) with a clinical diagnosis of stroke in the previous 2 to 15 days and persisting neurological deficit who were recruited at 43 hospital stroke units in Australia (n=29), New Zealand (4), and Vietnam (10) between 2013 and 2019. Participants were randomized to oral fluoxetine 20 mg once daily (n=642) or matching placebo (n=638) for 6 months and followed until 12 months after randomization. The primary outcome was function, measured by the modified Rankin Scale, at 6 months. Secondary outcomes for these analyses included measures of the modified Rankin Scale, mood, cognition, overall health status, fatigue, health-related quality of life, and safety at 12 months. Results: Adherence to trial medication was for a mean 167 (SD 48) days and similar between randomized groups. At 12 months, the distribution of modified Rankin Scale categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio, 0.93 [95% CI, 0.76–1.14]; P =0.46). Compared with placebo, patients allocated fluoxetine had fewer recurrent ischemic strokes (14 [2.18%] versus 29 [4.55%]; P =0.02), and no longer had significantly more falls (27 [4.21%] versus 15 [2.35%]; P =0.08), bone fractures (23 [3.58%] versus 11 [1.72%]; P =0.05), or seizures (11 [1.71%] versus 8 [1.25%]; P =0.64) at 12 months. Conclusions: Fluoxetine 20 mg daily for 6 months after acute stroke had no delayed or sustained effect on functional outcome, falls, bone fractures, or seizures at 12 months poststroke. The lower rate of recurrent ischemic stroke in the fluoxetine group is most likely a chance finding. REGISTRATION: URL: http://www.anzctr.org.au/ ; Unique identifier: ACTRN12611000774921